| Title : Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer - Narra_2007_Cancer.Biol.Ther_6_1691 |
| Author(s) : Narra K , Mullins SR , Lee HO , Strzemkowski-Brun B , Magalong K , Christiansen VJ , McKee PA , Egleston B , Cohen SJ , Weiner LM , Meropol NJ , Cheng JD |
| Ref : Cancer Biol Ther , 6 :1691 , 2007 |
| Abstract : Narra_2007_Cancer.Biol.Ther_6_1691 |
| ESTHER : Narra_2007_Cancer.Biol.Ther_6_1691 |
| PubMedSearch : Narra_2007_Cancer.Biol.Ther_6_1691 |
| PubMedID: 18032930 |
Narra K, Mullins SR, Lee HO, Strzemkowski-Brun B, Magalong K, Christiansen VJ, McKee PA, Egleston B, Cohen SJ, Weiner LM, Meropol NJ, Cheng JD (2007)
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer
Cancer Biol Ther
6 :1691
Narra K, Mullins SR, Lee HO, Strzemkowski-Brun B, Magalong K, Christiansen VJ, McKee PA, Egleston B, Cohen SJ, Weiner LM, Meropol NJ, Cheng JD (2007)
Cancer Biol Ther
6 :1691